Gemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter study

dc.contributor.authorInal, A.
dc.contributor.authorIsikdogan, A.
dc.contributor.authorKos, T.
dc.contributor.authorAlgin, E.
dc.contributor.authorGumus, M.
dc.contributor.authorDikilitas, M.
dc.contributor.authorElkiran, E. T.
dc.date.accessioned2024-04-24T17:14:58Z
dc.date.available2024-04-24T17:14:58Z
dc.date.issued2011
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1200/jco.2011.29.15_suppl.e14534
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15en_US
dc.identifier.urihttps://doi.org/10.1200/jco.2011.29.15_suppl.e14534
dc.identifier.urihttps://hdl.handle.net/11468/18277
dc.identifier.volume29en_US
dc.identifier.wosWOS:000208880303588
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherAmer Soc Clinical Oncologyen_US
dc.relation.ispartofJournal of Clinical Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleGemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter studyen_US
dc.titleGemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter study
dc.typeConference Objecten_US

Dosyalar